Since its inception in 1987, the Kansas City Classic at Tiffany Greens Golf Club has struggled to draw the Senior tour's heavy hitters. Last year's tournament, For example, featured six of the top 10 but none of the top four players on the final '98 money list, leaving George Brett (looping for pal Larry Ziegler, who won) as the most famous man on the scene. Which is why it's unfortunate that local hero Tom Watson, 49, will be three days too young to inject some life into this year's tournament.
Watson's business manager, Chuck Rubin, says his man would have played at Kansas City, which will run from Sept. 3 to Sept 5, but Senior rules state that a player must be 50 when he plays his first "obligated" round—in this case the Sept. 1 pro-am. Watson doesn't hit the half-century mark until Sept. 4. Neither Watson nor Rubin has complained, but others have.
"You can't let a guy play before he's 50," responds Senior tour spokesman Phil Stambaugh. "Otherwise you might as well let David Duval play. I had one radio station in Kansas City call me and say our rule is a crock."
New Drug Aimed At Lyme Disease
Smith Kline Beecham, having tested 10,936 people, has received approval from the Food and Drug Administration to market a product called LYMErix, the world's first vaccine against Lyme disease, which is transmitted mainly by deer ticks. Golfers are susceptible to the disease to the degree that they spend time in the rough. If untreated, Lyme can affect the victim's joints, heart and nervous system. Three LYMErix injections, spaced as directed, is the recommended dosage. With luck, next time you hook your ball into the woods, the only thing you'll have to worry about is finding it.